Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer.
Cowman SJ, Fuja DG, Liu XD, Tidwell RSS, Kandula N, Sirohi D, Agarwal AM, Emerson LL, Tripp SR, Mohlman JS, Stonhill M, Garcia G, Conley CJ, Olalde AA, Sargis T, Ramirez-Torres A, Karam JA, Wood CG, Sircar K, Tamboli P, Boucher K, Maughan B, Spike BT, Ho TH, Agarwal N, Jonasch E, Koh MY. Cowman SJ, et al. Among authors: fuja dg. Clin Cancer Res. 2020 Sep 15;26(18):4970-4982. doi: 10.1158/1078-0432.CCR-19-3890. Epub 2020 Jun 25. Clin Cancer Res. 2020. PMID: 32586940 Free PMC article.
ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma.
Green YS, Ferreira Dos Santos MC, Fuja DG, Reichert EC, Campos AR, Cowman SJ, Acuña Pilarte K, Kohan J, Tripp SR, Leibold EA, Sirohi D, Agarwal N, Liu X, Koh MY. Green YS, et al. Among authors: fuja dg. Oncogene. 2022 Oct;41(42):4709-4723. doi: 10.1038/s41388-022-02460-1. Epub 2022 Sep 12. Oncogene. 2022. PMID: 36097192 Free PMC article.
Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer.
Cowman SJ, Fuja DG, Liu XD, Tidwell RSS, Kandula N, Sirohi D, Agarwal AM, Emerson LL, Tripp SR, Mohlman JS, Stonhill M, Garcia G, Conley CJ, Olalde AA, Sargis T, Ramirez-Torres A, Karam JA, Wood CG, Sircar K, Tamboli P, Boucher K, Maughan B, Spike BT, Ho TH, Agarwal N, Jonasch E, Koh MY. Cowman SJ, et al. Among authors: fuja dg. Clin Cancer Res. 2021 Jun 1;27(11):3265. doi: 10.1158/1078-0432.CCR-21-1235. Clin Cancer Res. 2021. PMID: 34074655 No abstract available.
Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.
Roos A, Satterfield L, Zhao S, Fuja D, Shuck R, Hicks MJ, Donehower LA, Yustein JT. Roos A, et al. Among authors: fuja d. Br J Cancer. 2015 Nov 3;113(9):1289-97. doi: 10.1038/bjc.2015.305. Epub 2015 Oct 15. Br J Cancer. 2015. PMID: 26528706 Free PMC article.
Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.
Allen-Rhoades W, Kurenbekova L, Satterfield L, Parikh N, Fuja D, Shuck RL, Rainusso N, Trucco M, Barkauskas DA, Jo E, Ahern C, Hilsenbeck S, Donehower LA, Yustein JT. Allen-Rhoades W, et al. Among authors: fuja d. Cancer Med. 2015 Jul;4(7):977-88. doi: 10.1002/cam4.438. Epub 2015 Mar 17. Cancer Med. 2015. PMID: 25784290 Free PMC article.
11 results